You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for New Drug Application (NDA): 021985

✉ Email this page to a colleague

NDA 021985 describes TEKTURNA, which is a drug marketed by Noden Pharma and is included in three NDAs. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges. Additional details are available on the TEKTURNA profile page.

The generic ingredient in TEKTURNA is aliskiren hemifumarate; hydrochlorothiazide. There are four drug master file entries for this compound. Additional details are available on the aliskiren hemifumarate; hydrochlorothiazide profile page.

Summary for 021985

Tradename:	TEKTURNA
Applicant:	Noden Pharma
Ingredient:	aliskiren hemifumarate
Patents:	1

Pharmacology for NDA: 021985

Mechanism of Action	Renin Inhibitors

Suppliers and Packaging for NDA: 021985

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TEKTURNA	aliskiren hemifumarate	TABLET;ORAL	021985	NDA AUTHORIZED GENERIC	Prasco Laboratories	66993-141	66993-141-30	30 TABLET, FILM COATED in 1 BOTTLE (66993-141-30)
TEKTURNA	aliskiren hemifumarate	TABLET;ORAL	021985	NDA AUTHORIZED GENERIC	Prasco Laboratories	66993-142	66993-142-30	30 TABLET, FILM COATED in 1 BOTTLE (66993-142-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 150MG BASE
Approval Date:	Mar 5, 2007	TE:	AB	RLD:	Yes
Patent:	8,617,595*PED	Patent Expiration:	Aug 19, 2026	Product Flag?		Substance Flag?		Delist Request?	Y

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 300MG BASE
Approval Date:	Mar 5, 2007	TE:	AB	RLD:	Yes
Patent:	8,617,595*PED	Patent Expiration:	Aug 19, 2026	Product Flag?		Substance Flag?		Delist Request?	Y

Expired US Patents for NDA 021985

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Noden Pharma	TEKTURNA	aliskiren hemifumarate	TABLET;ORAL	021985-001	Mar 5, 2007	5,559,111*PED	⤷ Get Started Free
Noden Pharma	TEKTURNA	aliskiren hemifumarate	TABLET;ORAL	021985-002	Mar 5, 2007	5,559,111*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.